Omacor Soft Cap (omega-3 acid ethyl ester 90 1 g, DHA 380 mg, EPA 460 mg, Kuhnil Pharmaceutical Co., Ltd., Seoul, Korea) and Lipitor Tab (atorvastatin 40 mg, Pfizer Korea Ltd., Seoul, Korea) were used as the products for the study.
Lipitor tab
Manufactured by Pfizer
Lipitor Tab is a laboratory instrument used for the measurement and analysis of lipid levels in biological samples. It is designed to provide accurate and reliable data on the concentration of lipids, such as cholesterol and triglycerides, in a given sample. The device utilizes advanced technology to perform these measurements, but a detailed technical description is not available without the risk of bias or extrapolation.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using lipitor tab
1
Omega-3 and Atorvastatin Combination Study
2
Bioequivalence of Candesartan, Amlodipine, and Atorvastatin
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Study 1 A 16/10 mg Cantabell Tab (16 mg candesartan cilexetil and 10 mg amlodipine; Chong Kun Dang Pharm. Corp, Seoul, Republic of Korea) and a 40 mg Lipitor Tab (40 mg atorvastatin; Pfizer Inc., Seoul, Republic of Korea) were employed as reference drugs (individual formulations). A 16/5/40 mg dose of CKD-333 (16 mg candesartan cilexetil, 10 mg amlodipine, and 40 mg atorvastatin), manufactured by Chong Kun Dang Pharm. Corp (Seoul, Republic of Korea), was used as the test drug (FDC) in study 1. The investigational product, Cantabell Tab, used in these studies was confirmed in previous clinical trials to have pharmacokinetic characteristics bioequivalent to its individual formulations (ClinicalTrials.gov identifier NCT02548286), and no pharmacokinetic interactions have been observed between candesartan cilextil and amlodipine [38] (link). Therefore, although Cantabell Tab is not an individual formulation in the strict sense, we assumed that it has the same pharmacokinetics properties as the individual formulation.
Study 2 A 16/5 mg Cantabell Tab (16 mg candesartan cilexetil and 5 mg amlodipine) and a 20 mg Lipitor Tab (20 mg atorvastatin) were used as reference drugs and a 16/5/20 mg dose of CKD-333 (16 mg candesartan cilexetil, 5 mg amlodipine, and 20 mg atorvastatin) was used as the test drug (FDC) in study 2.
Study 2 A 16/5 mg Cantabell Tab (16 mg candesartan cilexetil and 5 mg amlodipine) and a 20 mg Lipitor Tab (20 mg atorvastatin) were used as reference drugs and a 16/5/20 mg dose of CKD-333 (16 mg candesartan cilexetil, 5 mg amlodipine, and 20 mg atorvastatin) was used as the test drug (FDC) in study 2.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!